Prevent Professional Research Subjects With The VCT Global Research Subject Database: European Snapshot

A quick look at some screening data in 3 close European countries demonstrates how research subjects travel to screen concurrently at multiple different sites. Professional research subjects often travel large distances between states or countries to do so. Some travel is within the same country to different sites, but there is significant travel between countries. …

Read more

Verified Clinical Trials Sees Progress In The Understanding and Acceptance of Duplicate Subjects In Clinical Trials

We have seen tremendous progress within the clinical trials research industry in understanding the scope of the issue with duplicate subjects in clinical trials  or professional research subjects over the past few years.  Verified Clinical Trials (VCT) provides an easy to implement cost-savings approach to prevent duplicate subjects and other important protocol violations in your …

Read more

Key Research Sites In Germany Join Verified Clinical Trials Research Subject Registry To Prevent Duplicate Subjects & Over Enrollment To Improve Safety & Data Quality

Several premier research centers in Germany have led the initiative and joined the global Verified Clinical Trials (VCT) research subject database registry to prevent duplicate subjects and other important protocol violations in an effort to improve safety and data quality in their clinical trials. Key research sites in Germany join Verified Clinical Trials to prevent …

Read more

Verified Clinical Trials Partners With The STARR Coalition To Promote Advocacy And Reduce Duplicate Subjects In CNS Clinical Trials

Verified Clinical Trials (VCT) the leading global research subject database registry has teamed up with the STARR Coalition to create Project RockSTARR. The initiative allows sponsors to have research subjects that screen for a clinical trial donate a pre-allocated amount of money to local advocacy group of their choice. Advocacy and duplicate subject prevention in …

Read more

No Specific Characteristics Of A Duplicate Subject And A Research Subject Database Is Required

Without a “tool” such as the Verified Clinical Trials (VCT) global research subjects database registry, detecting duplicate subjects and protocol violations based upon prior study history or prior study drug (IP) exposure is impossible. VCT proactively detects these issues at the time of screening before costly screening procedures occur. The protections continue the entire duration …

Read more

The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials

The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials. Verified Clinical Trials is a global research subject database registry. The registry is used by thousands of research sites across the US and in Europe to prevent many protocol deviations and most importantly, duplicate subjects in clinical …

Read more

Characteristics Of Professional Research Subjects and Duplicate Subjects In CNS and Other Clinical Trials Prevented By Verified Clinical Trials

Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data.  The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening.  What we have learned from experience and analytical data review over the …

Read more

Preventing Duplicate Subjects In European Clinical Trials: Average Travel Distance

Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries.  Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of …

Read more

Duplicate Subjects In Clinical Trials Prevented By Verified Clinical Trials

Duplicate subjects in clinical trials has attracted the attention of many clinical trial managers and study leads.  To prevent duplicate subjects or professional research subjects, many sponsors have added the use of Verified Clinical Trials (VCT) as a mandatory step during the screening process.  VCT verifies a research subject’s study history at the time of …

Read more

Duplicate Subjects In Your Clinical Trials Result In Safety & Data Quality Issues

To maintain data integrity and safety, it is necessary to highlight and detect duplicate subjects in your clinical trials proactively.  This is true for nearly all therapeutic indications and all phases of clinical trials research.  Duplicate enrollment (over enrollment) is NOT just a healthy volunteer phase 1 issue.  The global research subject database registry VCT data over the …

Read more